Pollak M - Search Results

1

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.

Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D, Chu W, Ho M, Sweet J, Evans A, Toi A, Pollak M, Narod SA. Nam RK, et al. Among authors: pollak m. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1429-37. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693733 Clinical Trial.

2

Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.

Huynh HT, Larsson C, Narod S, Pollak M. Huynh HT, et al. Among authors: pollak m. Cancer Res. 1995 Jun 1;55(11):2225-31. Cancer Res. 1995. PMID: 7757968

3

Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas.

Sekyi-Otu A, Bell RS, Ohashi C, Pollak M, Andrulis IL. Sekyi-Otu A, et al. Among authors: pollak m. Cancer Res. 1995 Jan 1;55(1):129-34. Cancer Res. 1995. PMID: 7805022

4

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN. Foulkes WD, et al. Among authors: pollak mn. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2465-9. Clin Cancer Res. 1997. PMID: 9815648

5

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. Giovannucci E, et al. Among authors: pollak mn. Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):345-9. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10794477

6

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, Bégin LR. Foulkes WD, et al. Among authors: pollak mn. Ann Oncol. 2000 Mar;11(3):307-13. doi: 10.1023/a:1008340723974. Ann Oncol. 2000. PMID: 10811497 Free article.

7

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.

Jernström H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA. Jernström H, et al. Among authors: pollak m. Mol Genet Metab. 2001 Feb;72(2):144-54. doi: 10.1006/mgme.2000.3130. Mol Genet Metab. 2001. PMID: 11161840

8

Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.

Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M. Jernström H, et al. Among authors: pollak m. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):377-84. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11319179

9

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: pollak m. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352850

10

Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.

Holmes MD, Pollak MN, Willett WC, Hankinson SE. Holmes MD, et al. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):852-61. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12223429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

860 results

Search Page

Filters